Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

Vaginal mesh ineffective and dangerous, study shows

Posted in Vaginal Mesh

Transvaginal mesh (TVM) is a mesh implant used to treat damaged vaginal tissues.  One condition TVM has been commonly used to treat is called pelvic organ prolapse (POP).  POP is characterized by weakening of the tissues that hold the pelvic organs in place, and occurs in 30-50% of women.

An observational study, titled “Total transvaginal mesh (TVM) technique for treatment of pelvic organ prolapse: a 5-year prospective follow-up study”, conducted by Bernard Jacquetin, et al. and published by The International Urogynecological Association in 2010, evaluated the long term effectiveness of procedures using TVM.  More specifically, the purpose of the study was “to assess effectiveness, both anatomical and subjective, and complications for the TVM technique for POP repair.”  The evaluations were conducted up to three years after implantation of TVM, with additional future evaluations scheduled at 5 years post-implantation.  Subjects included women over the age of 21 treated for either anterior or posterior damage, and having already undergone a hysterectomy to limit confounding factors.  Women suffering from uncontrolled diabetes or coagulation disorders were not included in the data set.

Effectiveness of TVM was evaluated based on “prolapse recurrence, defined as a POP-Q Stage II or more…or surgical intervention for recurrence of prolapse.”  The data revealed an anatomical success rate of 81.2% three years post-operation; which is not significantly different from the success rate of 81.6% at one year post-implantation.

Some confounding variables in the study include the fact that different cuts of TVM, and different needles, were used depending on the nature of the procedure; therefore, the study technically did not evaluate a “standard” procedure.  Ultimately the study concluded that transvaginal mesh, may in fact be a reliable solution for surgical repair of damaged vaginal tissues, stating that “the early positive anatomical findings and positive impact on patients’ quality of life scores are sustained after 3 years.  The TVM procedure is associated with a high total reintervention rate (13.3%) but the low re-intervention rate for prolapse (3.3%) suggests that a total vaginal mesh seems to lead to a stable repair of the pelvic floor.”

Unfortunately, and in light of the publication of many similar studies showing the danger of transvaginal mesh, the many TVM product manufacturers have failed to warn women of the risks associated with their products.  Because of this, a number of vaginal mesh lawsuits have been filed.

If you or a loved one used TVM and suffered a TVM side effect such as vaginal mesh erosion, vaginal mesh infection, or another TVM complication, contact our team of vaginal mesh lawyers at the information provided below for a free, no-obligation case consultation.

(855) 452-5529

justinian@dangerousdrugs.us

Our Transvaginal Mesh Lawsuit Information page is a great place to start if you have any questions about Transvaginal Mesh.